Items where authors include "Ward, T."
Article
Abani, O., Abbas, A., Abbas, F. et al. (8041 more authors) (2025) Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Infectious Diseases. ISSN 1473-3099
Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. eClinicalMedicine, 81. 103080. ISSN 2589-5370
Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. EClinicalMedicine, 81. 103080. ISSN 2589-5370
Wakefield, D. orcid.org/0000-0002-6811-1255, Ward, T., Edge, H. orcid.org/0009-0002-5926-605X et al. (2 more authors) (2025) Palliative and end-of-life care for patients with pleural mesothelioma: a cohort study. Palliative Medicine, 39 (2). pp. 286-297. ISSN 0269-2163
Smith, R.A. orcid.org/0000-0003-0245-3217, Samyshkin, Y. orcid.org/0000-0003-3561-5585, Mohammed, W. orcid.org/0000-0003-0370-4903 et al. (14 more authors) (2024) assertHE: an R package to improve quality assurance of HTA models [version 1; peer review: 1 approved with reservations]. Wellcome Open Research, 9. 701. ISSN 2398-502X
Greenwood, D.C. orcid.org/0000-0001-7035-3096, Mansoubi, M., Bakerly, N.D. et al. (18 more authors) (2024) Physical, cognitive, and social triggers of symptom fluctuations in people living with long COVID: an intensive longitudinal cohort study. The Lancet Regional Health - Europe, 46. 101082. ISSN 2666-7762
Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642
Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642
Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology, 11 (12). pp. 905-914. ISSN 2213-8587
Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 401 (10387). pp. 1499-1507. ISSN 0140-6736
Arvaneh, M., Roertson, I. and Ward, T. (2019) A P300-Based Brain-Computer Interface for Improving Attention. Frontiers in Human Neuroscience, 12. 524. ISSN 1662-5161
Battaglieri, M., Belloni, A., Chou, A. et al. (248 more authors) (2017) US Cosmic Visions: New Ideas in Dark Matter 2017: Community Report. arXiv. (Submitted)